Analysis of ponatinib-resistant Ba/F3 BCR-ABL cells.
- Seiichi Okabe (529221)
- Tetsuzo Tauchi (529222)
- Shinya Kimura (247648)
- Taira Maekawa (247655)
- Toshihiko Kitahara (529223)
- Yoko Tanaka (52010)
- Kazuma Ohyashiki (229098)
Publication date
February 2014
DOIAbstract
<p>(A) Ba/F3 ponatinib-resistant cells were treated with various concentrations of imatinib, nilotinib, or dasatinib, and cellular growth was analyzed. These experiments were performed in triplicate. (B) Ba/F3 ponatinib-resistant cells were treated with imatinib, nilotinib, or dasatinib for 24 h. Whole cell lysates were analyzed by immunoblotting with phospho-specific Abl and Crk-L Abs. β-tubulin was used as the loading control.</p
Add to ORKG